<DOC>
	<DOCNO>NCT00976092</DOCNO>
	<brief_summary>Randomized comparison two different anticoagulation strategy : prasugrel plus bivalirudin versus clopidogrel plus heparin patient acute myocardial infarction undergo emergency catheterization coronary intervention .</brief_summary>
	<brief_title>Efficacy Study Combined Prasugrel Bivalirudin Versus Clopidogrel Heparin Myocardial Infarction</brief_title>
	<detailed_description>Primary percutaneous coronary intervention ( PPCI ) prefer reperfusion strategy patient acute ST-segment elevation myocardial infarction ( STEMI ) . Additional anticoagulation therapy prior intervention play important role short- long-term outcome PPCI . Two separate study show significant benefit conventional therapy base clopidogrel heparin two recently approve drug : direct thrombin inhibitor bivalirudin thienopyridine prasugrel . In HORIZONS-AMI trial , bivalirudin pretreatment clopidogrel result improved net clinical outcome . However , first 24 hour PPCI increase stent thrombosis rate observe bivalirudin therapy . Prasugrel show superior clopidogrel patient acute coronary syndrome undergo PCI . The benefit reduction ischemic complication even great subset patient STEMI without increase bleeding risk significant reduction stent thrombosis rate . Expectedly , synergic action prasugrel bivalirudin may maximize benefit antithrombotic therapy STEMI patient undergo PPCI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<criteria>1 . Patients present within 24 hour onset symptom STEMI 2 . Informed , write consent 3 . In woman childbearing potential pregnancy test obligatory . 1 . Age &lt; 18 year 2 . Cardiogenic shock 3 . Active bleeding ; bleed diathesis ; coagulopathy 4 . History gastrointestinal genitourinary bleeding &lt; 2 month 5 . Refusal receive blood transfusion 6 . Major surgery last 6 week 7 . History intracranial bleed structural abnormality 8 . Suspected aortic dissection 9 . Heparininduced thrombocytopenia 10 . Any previous stroke 11 . Prior administration thrombolytic , bivalirudin , lowmolecular weight heparin fondaparinux index MI 12 . Known relevant hematological deviation : Hb &lt; 100g/l , Thromb . &lt; 100x10^9/l 13 . Use coumadin derivative within last 7 day 14 . Chronic therapy nonsteroidal antiinflammatory drug ( except aspirin ) , COX2 inhibitor , prasugrel 15 . Known malignancy comorbid condition life expectancy &lt; 1 year 16 . Known severe liver disease , severe renal failure 17 . Known allergy study medication 18 . Previous enrollment trial 19 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>prasugrel</keyword>
	<keyword>bivalirudin</keyword>
	<keyword>primary PCI</keyword>
</DOC>